ProQR announces first participant dosed in Phase 1 of AX-0811
ProQR says it has dosed the first participant in its Phase 1 study of AX-0811.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.